Squarepoint’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.1M Buy
479,394
+262,370
+121% +$3.88M 0.01% 674
2025
Q1
$3.89M Buy
217,024
+199,468
+1,136% +$3.57M ﹤0.01% 865
2024
Q4
$306K Sell
17,556
-11,006
-39% -$192K ﹤0.01% 2176
2024
Q3
$400K Buy
28,562
+12,982
+83% +$182K ﹤0.01% 1871
2024
Q2
$128K Sell
15,580
-8,491
-35% -$69.8K ﹤0.01% 2225
2024
Q1
$186K Sell
24,071
-101,708
-81% -$784K ﹤0.01% 2108
2023
Q4
$1.13M Buy
125,779
+97,354
+342% +$875K ﹤0.01% 1298
2023
Q3
$254K Sell
28,425
-131,873
-82% -$1.18M ﹤0.01% 2014
2023
Q2
$2.46M Buy
160,298
+1,478
+0.9% +$22.7K 0.01% 816
2023
Q1
$3.57M Buy
158,820
+144,584
+1,016% +$3.25M 0.01% 624
2022
Q4
$299K Sell
14,236
-30,487
-68% -$641K ﹤0.01% 1708
2022
Q3
$1.1M Buy
44,723
+30,360
+211% +$748K 0.01% 1029
2022
Q2
$348K Buy
+14,363
New +$348K ﹤0.01% 1517
2021
Q4
Sell
-13,069
Closed -$317K 2823
2021
Q3
$317K Sell
13,069
-45,061
-78% -$1.09M ﹤0.01% 1613
2021
Q2
$848K Buy
58,130
+27,621
+91% +$403K ﹤0.01% 1291
2021
Q1
$762K Buy
30,509
+13,496
+79% +$337K ﹤0.01% 1265
2020
Q4
$464K Buy
17,013
+5,496
+48% +$150K ﹤0.01% 1552
2020
Q3
$213K Sell
11,517
-2,365
-17% -$43.7K ﹤0.01% 1898
2020
Q2
$283K Buy
+13,882
New +$283K ﹤0.01% 1591
2019
Q3
Sell
-50,208
Closed -$1.01M 2557
2019
Q2
$1.01M Sell
50,208
-31,282
-38% -$629K 0.01% 1240
2019
Q1
$1.84M Buy
81,490
+1,597
+2% +$36.1K 0.02% 804
2018
Q4
$1.81M Buy
79,893
+35,137
+79% +$795K 0.02% 700
2018
Q3
$1.29M Buy
44,756
+4,115
+10% +$118K 0.02% 882
2018
Q2
$1.11M Buy
40,641
+28,941
+247% +$789K 0.01% 855
2018
Q1
$262K Buy
+11,700
New +$262K ﹤0.01% 1372
2017
Q4
Sell
-12,030
Closed -$299K 2337
2017
Q3
$299K Buy
+12,030
New +$299K 0.01% 1171
2017
Q1
Sell
-12,428
Closed -$235K 1914
2016
Q4
$235K Buy
+12,428
New +$235K 0.01% 1315
2016
Q2
Sell
-10,400
Closed -$142K 1351
2016
Q1
$142K Sell
10,400
-4,800
-32% -$65.5K 0.01% 1045
2015
Q4
$293K Buy
+15,200
New +$293K 0.03% 802